This opportunity enables investigators to obtain biospecimens including urine, plasma, serum, and genomic DNA from the PATH Study, along with associated behavioral and health data. Funded activities focus on research into tobacco use behaviors, biomarkers, and health outcomes using these resources.
Eligible applicants include a wide range of U.S. entities such as state and local governments, higher education institutions, nonprofits, small businesses, tribal governments, and certain federally recognized organizations. Non-U.S. entities and foreign components are not eligible.
